含复方尿囊素四联疗法治疗幽门螺杆菌感染慢性胃炎的疗效  被引量:40

Efficacy of compound allantoin containing quadruple Helicobacter pylori infection

在线阅读下载全文

作  者:崔梅花[1] 魏红[1] 雷晓燕[1] 戴立娜 马志琳 

机构地区:[1]航天中心医院(北京大学航天临床医学院)消化科,北京100049

出  处:《中华消化杂志》2014年第5期297-301,共5页Chinese Journal of Digestion

摘  要:目的评价含复方尿囊素四联10 d疗法对H.pylori感染的慢性胃炎患者的疗效,并与含铋剂四联疗法进行比较。方法173例经胃镜证实的H.pylori阳性慢性胃炎患者,分为含尿囊素四联10 d组(43例)、含尿囊素四联24 d组(46例)、含铋剂四联10 d组(42例)和含铋剂四联24 d组(42例)。治疗结束后观察各组患者H.pylori根除率、胃肠道症状(上腹痛、腹胀、嗳气)缓解率和不良反应等。采用意向性分析和符合方案分析,行卡方检验。结果含尿囊素四联10 d组、含尿囊素四联24 d组、含铋剂四联10 d组和含铋剂四联24 d组的H.pylori根除率,行意向性分析分别为90.7%(39/43)、91.3%(42/46)、90.5%(38/42)和88.1%(37/42),行符合方案分析分别为90.7%(39/43)、93.3%(42/45)、90.5%(38/42)和90.2%(37/41),各组比较差异均无统计学意义(P均〉O.05)。治疗后10 d,含尿囊素四联24 d组和含铋剂四联24 d组的上腹痛缓解率分别为81.1%(30/37)和78.8%(26/33),腹胀缓解率分别为82.4%(28/34)和71.0%(22/31),嗳气缓解率分别为76.9%(20/26)和75.0%(21/28),两组比较差异均无统计学意义(P均〉O.05);治疗后24 d,含尿囊素四联24 d组和含铋剂四联24 d组的上腹痛缓解率分别为91.9%(34/37)和87.9Yoo(29/33),腹胀缓解率分别为94.1%(32/34)和87.1%(27/31),嗳气缓解率分别为96.2%(25/26)和85.7%(24/28),两组比较差异均无统计学意义(P均〉O.05)。两组上腹痛和腹胀缓解率在治疗后24 d比治疗后10 d均有提高,但差异均无统计学意义(P均〉O.05),而含尿囊素四联24 d组的嗳气缓解率在治疗后24 d高于治疗后10 d,差异有统计学意义(x2=4.127,p=0.042)。各组均无严重不良反应发生,含尿囊素四�Objective To evaluate the efficacy of 10-day compound allantoin containing quadrupleregimen in the treatment of chronic gastritis with Helicobacter pylori (H. pylori) infection, and tocompare with the bismuth-containing quadruple therapy. Methods Altogether 173 patients withH. pylori positive chronic gastritis confirmed by gastric endoscope were divided into 10-day compoundallantoin containing quadruple regimen group (n = 43), 24-day compound allantoin containing quadrupleregimen group (n = 46), 10-day bismuth-containing quadruple regimen group (n = 42) and 24-daybismuth-containing quadruple regimen group (n = 42). After the treatment, the eradication rate ofH. pylori, the rate of gastrointestinal symptoms (epigastric pain, bloating and belching) relief and theadverse effects of each group were observed. Intention-to-treat (ITT), per-protocol (PP) statisticalanalysis and chi-square analysis were performed for statistical analysis. Results H. pylori eradicationrates of 10-day compound allantoin containing quadruple regimen group, 24-day compound allantoin containing quadruple regimen group, 10-day bismuth-containing quadruple regimen group and 24-day bismuth-containing quadruple regimen group analyzed by ITT were 90. 7% (39/43), 91. 3% (42/46), 90.5% (38/42) and 88.1%(37/42), respectively; while analyzed by PP were 90.7% (39/43), 93.3% (42/45), 90.5% (38/42) and 90.2% (37/41), respectively. And there were no statistical differences between groups (all P〉0.05). Ten days after the treatment, the rates of epigastric pain relief of 24-day compound allantoin containing quadruple regimen group and 24-day bismuth-containing quadruple regimen group were 81.1% (30/37) and 78.8% (26/33), respectively, the rates of bloating relief were 82.4% (28/34) and 71. 0% (22/31), respectively, and the rates of belching relief were 76. 9% (20/26) and 75.0% (21/28), respectively. There were no statistical differences between the two groups fall

关 键 词:尿囊素  质子泵抑制剂 螺杆菌 幽门 

分 类 号:R573.3[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象